Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland

INTRODUCTION: Omalizumab has been successfully used as a supplementary therapy to improve asthma control in children aged ≥ 6 years with moderate or severe persistent allergic asthma. AIM: To evaluate effectiveness ofomalizumab in children and adolescents with uncontrolled allergic asthma. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Sztafińska, Anna, Gwardys, Mikołaj, Podlecka, Daniela, Mospinek, Ewa, Stelmach, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330849/
https://www.ncbi.nlm.nih.gov/pubmed/34377123
http://dx.doi.org/10.5114/ada.2021.107929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330849/
https://www.ncbi.nlm.nih.gov/pubmed/34377123
http://dx.doi.org/10.5114/ada.2021.107929

Ejemplares similares